Natural history of chronic hepatitis B;História natural da hepatite crônica B

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 40, Issue 6, 2007, Pages 672-677

  Da Fonseca, José Carlos Ferraz ^a,b  

^a FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

^b NONE   (Brazil)

Author keywords

Chronic hepatitis; Hepatitis B virus; Liver cirrhosis; Natural history

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC DISEASE; DECOMPENSATED LIVER CIRRHOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; HEPATITIS B; HEPATITIS B VIRUS; HISTORY; HUMAN; IMMUNOLOGICAL TOLERANCE; LIVER CANCER; LIVER CIRRHOSIS; LIVER DISEASE; NONHUMAN; REVIEW; SERODIAGNOSIS;

HEPATITIS B VIRUS;

EID: 38349185351     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822007000600015     Document Type: Review

References (42)

1. Bonino F, Brunetto MR. Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview. Journal of Hepatology 39: S160-S163, 2003.
2. Bouchard MJ, Schneider RJ. The enigmatic X gene of hepatitis B virus. Journal of Virology 78: 12725-12734, 2004.
3. Bréchot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127: S56-S61, 2004.
4. Chen A-J. Time dependents events in natural history of occult hepatitis B virus infection: the importance of population-based long-term follow-up study with repeated measurements. Journal of Hepatology 42: 438-440, 2005
5. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH, Reveal-HBV Study Group. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. Journal of American Medical Association 295: 65-73, 2006.
6. Chu C-J, Lok AS. Clinical utility in quantifying serum HBV-DNA levels using PCR assays. Journal of Hepatology 36: 549-551, 2002.
7. Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology 45: 1187-1192, 2007.
8. Conjeevaram HS, Lok AS. Management of chronic hepatitis B. Journal of Hepatology 38: S90-S103, 2003.
9. Fattovich G. Natural history of hepatitis B. Journal of Hepatology 39: S50-S58, 2003.
10. Fattovich G, Olivari, Pasino M, D' Onofrio M, Martone E, Donato F. Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years. GUT. Published Online First: 22 August 2007. doi:10.1136/gut.2007. 128496, 2007.
11. Fonseca JCF. Hepatite Delta. Revista da Sociedade Brasileira de Medicina Tropical 35: 181-190, 2002.
12. Fung SK, Lok ASF. Management of patients with hepatitis B virus-induced cirrhosis. Journal of Hepatology 42: S54-S64, 2005.
13. Gaeta GB, Precone DF, Cozzi-Lepri A, Cicconi P, D'Arminio Monforte A. Multiple viral infections. Journal of Hepatology 44: 108-113, 2006.
14. Ganem D, Prince AM. Hepatitis B virus infection - Natural history and clinical consequences. The New England Journal of Medicine 350: 1118-1129, 2004.
15. Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34: 617-624, 2001.
16. Hatzakis A, Magiorkinis, E Haida C. HBV virological assessment. Journal of Hepatology 44: 71-76, 2006.
17. Hui CK, Leung N, Shek TW, Yao H, Lee WK, Lai JY, Lai ST, Wong WM, Lai LS, Poon RT, Lo CM, Fan ST, Lau GK, Hong Kong Liver Fibrosis Study Group. Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients.Hepatology 43: 690-698, 2007.
18. Hui CK, Leung N, Yuen ST, Zhang HY, Leung KW, Lu L, Cheung SK, Wong WM, Lau GK, Hong Kong Liver Fibrosis Study Group. Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology 46: 395-401, 2007.
19. Hunt CM, McGill JM, Allen ML, Condreay LD. Clinical relevance of hepatitis B viral mutations. Hepatology 31: 1037-1044, 2000.
20. Kao J-H, Chen P-J, Lai M-Y, Chen DS. Acute exacerbations of chronic hepatitis B are rarely associated with superinfection of hepatitis B virus. Hepatology 34: 817-823, 2001.
21. Kidd-Ljunggren, Miyakawa Y, Kidd AH. Genetic variability in hepatitis B viruses. Journal of General Virology 83: 1267-1280, 2002.
22. Koziel MJ, Peters MG. Viral hepatitis in HIV infection. The New England Journal of Medicine 356: 1445-1454, 2007.
23. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treat, and current and emerging and control measures. Journal of Viral hepatitis 11: 97-107, 2004.
24. Lee WM. Hepatitis B virus infection. The New England Journal of Medicine 337: 1773-1745, 1997.
25. Liang TJ, Ghany M. Hepatitis B e antigen - The dangerous endgame of hepatitis B. The New England Journal of Medicine 347: 208-210, 2002.
26. Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterolgy 126: 1024-1029, 2004.
27. Liu CJ, Kao JH. Hepatitis B virus genotype: what the should clinician know? Current Hepatitis Reports 6: 17-23, 2007.
28. Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, Yeh SH, Chen PJ, Chen DS. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. Journal of Hepatology 44: 39-46, 2006.
29. Locarnini S. Hepatitis B viral resistance: mechanisms and diagnosis. Journal of Hepatology 39: S124-S132, 2003.
30. Locarnini S. Molecular virology of hepatitis B virus. Seminars in Liver Disease 24 (supplement 1): 3-10, 2004.
31. Lok ASF. Occult hepatitis B virus infection: diagnosis, implication and management. Journal Gastrenterology Hepatology 19: S114-S117, 2004.
32. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 45: 507-539, 2007.
33. McMahon BJ. The natural history of chronic hepatitis B virus infection. The New England Journal of Medicine 337: 1773-1745, 1997.
34. Neumann AU. Hepatitis B viral kinects: A dynamic puzzle still to be resolved. Hepatology 42: 249-254, 2005.
35. Perrilo RP. Acute flares in chronic hepatitis B: The natural an unnatural history of an immunologically mediated liver disease. Gastroenterolgy 120: 1009-1022, 2001.
36. Puoti M, Torti C, Bruno R, Felice G, Carosi G. Natural history of chronic hepatitis B in co-infected patients. Journal of Hepatology 44: S65-S70, 2006.
37. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. Journal of Hepatology 46: 160-170, 2007.
38. Raimondo G, Pollicino T, Squadrito G. Clinical virology of hepatitis B virus infection. Journal of Hepatology 39: S26-S30, 2003.
39. Toan, NL, Song LH, Kremsner PG, Duy DN, Binh VQ, Duechting A, Kaiser H, Torresi J, Kandolf R, Bock CT. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection. Journal of Hepatology 45: 361-369, 2006.
40. Wright TL. Introduction to chronic hepatitis B infection. The American Journal of Gastroenterolgy 101: S1-S6, 2006.
41. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS. Hepatitis B e antigen and the risk of hepatocellular carcionoma. The New England Journal of Medicine 347: 168-174, 2002.
42. Yuan HJ, Yuen MF, Ka-Ho Wong D, Sablon E, Lai CL.The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B. Journal of Viral Hepatitis 12: 373-379, 2005.